- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
NANOFS
STO
Week ended 07 Aug 2026
Weekly Investor Report
Nanoform Finland Oyj · Healthcare · Biotechnology
Latest close
10.70 SEK
15.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 29.8% above the Trend Line and sits at 59.2% of its 52-week range. The latest completed week returned 15.3%, after a 26.8% four-week move. The latest news-sentiment score is 50/100.
Setup score
44
out of 100
Latest Close
10.70 SEK
7 Aug 2026
1W Return
15.3%
latest completed week
4W Return
26.8%
short-term follow-through
12W Return
11.5%
quarterly tape
Trend Breadth
23.1%
12 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 31.50% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
15.3%
Latest completed week; four-week move 26.8%.
Indicator stack
20/65
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 31.50%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 29.8% above the Trend Line and sits at 59.2% of its 52-week range. The latest completed week returned 15.3%, after a 26.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3012-week average 0.20
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.30Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 26.8% over four weeks, 11.5% over 12 weeks, and -1.9% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year12
Trend breadth23.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.64Latest activity-pressure read.
Pressure change44.2%Four-week change in activity pressure.
Leadership-0.29Latest relative-leadership reading.
RS change98.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.7%Distance below the 52-week high.
13-week volatility14.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2617 weeks finished lower.
Best week+45.0%Week of 15 May.
Worst week-28.5%Week of 3 Apr.
Latest week+15.3%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains1
Flat weeks0
Modest losses6
Sharp losses11
Recent vol14.2%13-week weekly-return volatility.
Base vol12.6%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew13.0% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank1 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Biotechnology
4-week rank5 / 58
Group average3.5%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD53.4%positive activity pressure
RS22.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape36/100
Trend, activity pressure, participation, and risk combine to a 36/100 tape read.
Indicator analysis39/100Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.30; No reversal markers Next-Week ExpectancyNegative 31.50%Next-week expectancy is negative with a 31.50% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Nanoform Finland Oyj: Target Price Consensus and Analysts Recommendations | NANOFH | FI4000330972 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 10.70 SEK | 15.3% | 8.24 SEK | 15.81 SEK | 0.64 | -0.29 | 92.0K | On |
| 31 Jul 2026 | 9.28 SEK | -0.7% | 8.25 SEK | 15.87 SEK | 0.49 | -12.28 | 27.6K | On |
| 24 Jul 2026 | 9.35 SEK | 4.0% | 8.37 SEK | 15.95 SEK | 0.44 | -11.20 | 28.6K | Off |
| 17 Jul 2026 | 8.99 SEK | 6.5% | 8.46 SEK | 16.03 SEK | 0.41 | -13.95 | 12.3K | Off |
| 10 Jul 2026 | 8.44 SEK | -1.2% | 8.55 SEK | 16.10 SEK | 0.45 | -20.76 | 14.5K | Off |
| 3 Jul 2026 | 8.54 SEK | -2.1% | 8.65 SEK | 16.18 SEK | 0.49 | -22.51 | 3.5K | Off |
| 26 Jun 2026 | 8.72 SEK | -6.5% | 8.72 SEK | 16.27 SEK | 0.61 | -19.59 | 4.4K | Off |
| 19 Jun 2026 | 9.33 SEK | -1.8% | 8.77 SEK | 16.37 SEK | 0.73 | -15.37 | 18.3K | Off |
| 12 Jun 2026 | 9.50 SEK | -9.7% | 8.82 SEK | 16.48 SEK | 0.87 | -13.14 | 7.6K | Off |
| 5 Jun 2026 | 10.52 SEK | -4.9% | 8.89 SEK | 16.59 SEK | 1.00 | -4.24 | 9.2K | Off |
| 29 May 2026 | 11.06 SEK | 19.6% | 8.93 SEK | 16.69 SEK | 0.69 | -0.19 | 118.0K | Off |
| 22 May 2026 | 9.25 SEK | -3.6% | 8.97 SEK | 16.79 SEK | 0.11 | -16.95 | 354.9K | Off |
| 15 May 2026 | 9.60 SEK | 45.0% | 9.10 SEK | 16.90 SEK | -0.54 | -11.42 | 473.2K | Off |
| 8 May 2026 | 6.62 SEK | 32.7% | 9.16 SEK | 17.00 SEK | -1.21 | -39.92 | 120.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.